Q3 Earnings Estimate for Danaher Issued By Leerink Partnrs

Danaher Corporation (NYSE:DHR - Free Report) - Equities researchers at Leerink Partnrs increased their Q3 2026 EPS estimates for Danaher in a report issued on Tuesday, October 21st. Leerink Partnrs analyst P. Souda now forecasts that the conglomerate will earn $1.92 per share for the quarter, up from their prior estimate of $1.83. The consensus estimate for Danaher's current full-year earnings is $7.63 per share.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, beating analysts' consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The firm had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. During the same period in the previous year, the firm posted $1.71 earnings per share. The firm's revenue was up 4.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS.

DHR has been the subject of a number of other reports. Evercore ISI lifted their target price on shares of Danaher from $226.00 to $245.00 and gave the company an "outperform" rating in a research note on Tuesday, October 7th. Wall Street Zen raised shares of Danaher from a "hold" rating to a "buy" rating in a report on Friday, June 27th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Danaher from $235.00 to $250.00 and gave the stock a "buy" rating in a report on Wednesday. UBS Group dropped their price objective on shares of Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a report on Wednesday, July 23rd. Finally, TD Cowen increased their target price on shares of Danaher from $250.00 to $260.00 and gave the company a "buy" rating in a research note on Wednesday. Eighteen research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Danaher presently has a consensus rating of "Moderate Buy" and a consensus price target of $243.39.

Danaher Stock Performance

Shares of NYSE DHR opened at $222.62 on Friday. The company has a market capitalization of $157.25 billion, a P/E ratio of 45.90, a price-to-earnings-growth ratio of 3.31 and a beta of 0.77. The business's 50-day moving average price is $202.49 and its two-hundred day moving average price is $198.02. Danaher has a one year low of $171.00 and a one year high of $258.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.22.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher's dividend payout ratio is 27.23%.

Insider Buying and Selling at Danaher

In related news, Director Teri List sold 2,778 shares of Danaher stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director owned 20,751 shares of the company's stock, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 11.10% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Danaher

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Sumitomo Mitsui DS Asset Management Company Ltd grew its holdings in shares of Danaher by 4.0% in the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 88,853 shares of the conglomerate's stock valued at $17,616,000 after buying an additional 3,381 shares during the period. Fjell Capital LLC grew its stake in Danaher by 2.8% in the third quarter. Fjell Capital LLC now owns 2,519 shares of the conglomerate's stock valued at $499,000 after acquiring an additional 68 shares during the period. Valmark Advisers Inc. increased its holdings in shares of Danaher by 5.1% in the third quarter. Valmark Advisers Inc. now owns 2,334 shares of the conglomerate's stock worth $463,000 after acquiring an additional 113 shares in the last quarter. Pioneer Trust Bank N A OR raised its position in shares of Danaher by 1.0% during the third quarter. Pioneer Trust Bank N A OR now owns 29,641 shares of the conglomerate's stock worth $5,877,000 after purchasing an additional 280 shares during the period. Finally, Oregon Public Employees Retirement Fund raised its position in shares of Danaher by 32.3% during the third quarter. Oregon Public Employees Retirement Fund now owns 72,827 shares of the conglomerate's stock worth $14,439,000 after purchasing an additional 17,790 shares during the period. 79.05% of the stock is owned by institutional investors.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.